跳至主要内容
临床试验/NCT05686135
NCT05686135撤回不适用

90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients

Jennifer Jones2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2023年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
500
试验地点
2
主要终点
Self Efficacy

研究概览

简要总结

Patients with Inflammatory Bowel Disease (IBD) have poorer quality of life than healthy people. Despite the high prevalence of psychological issues and its profound influence on quality of life, most IBD patients have limited access to mental health support. As well, many may decline support if it is offered because mental health is often not thought of as part of IBD care. Patients may be able to access cognitive behavioural therapy (CBT) through a psychologist, however this intervention is costly and requires considerable commitment on the part of person with IBD. There is a need for new methods of reaching IBD patients to provide information on their psychological needs, and normalize the psychological effects of IBD. These new methods should integrate medical issues with psychosocial issues while being effective, scalable, and low cost to the health care system. 90SecondIBD is a novel way of delivering health information about IBD using Persuasive Design technology embedded in a planned behavior model. This project will investigate the effect of the intervention "90SecondIBD", a weekly online health letter, on IBD patients' quality of life and self efficacy. Regression modelling will be performed to explore the ability of clinical and demographic factors to predict quality of life and self efficacy scores following receipt of 90SecondIBD educational health letters weekly for 6 months and 12 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult, resident of Canada, diagnosis of IBD, access to a computer or cell phone

排除标准

  • 未提供

结局指标

主要结局

Self Efficacy

时间窗: month 12

Participant self-efficacy rating measured using the 'New General Self Efficacy Scale'. Min score: 1, max score: 8. A higher score indicates a greater self-efficacy.

IBD Specific Quality of life

时间窗: month 12

IBD specific quality of life, measured using the Short Inflammatory Bowel Disease Questionnaire (SIBDQ). The SIBDQ comprises a total of 10 questions grouped into four domains: bowel symptoms, emotional health, systemic systems and social function. Each question is scored by a 7-point Likert scale, ranging from 1 to 7, giving an absolute score ranging from 10 (poor health related QoL) to 70 (optimal health related QoL).

次要结局

  • Participant Satisfaction with 90SecondIBD(month 12)

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jennifer Jones

Gastroenterologist

Nova Scotia Health Authority

研究点 (2)

Loading locations...

相似试验